Compass Therapeutics LLC
Amendment
CIK: 0001610824·Biotechnology·DELAWARE·Filed: Sep 21, 2016
Total Offering
$170,205,999
Amount Sold
$45,977,738
Investors
17
First Sale
Jun 17, 2015
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Limited Liability Company
- Year Incorporated
- 2014
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Errik Anderson | Related Person |
| Thomas Schuetz | Related Person |
| Steve Tregay | Related Person |
| Ben Auspitz | Related Person |
| Philip Ferneau | Related Person |
| Carl Gordon | Related Person |
| Stephen Squinto | Related Person |
Company
SEC Filing
0001610824-16-000004
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free